Author

X. Chai

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:development & morphogenesis· 1 Organism:human· 1 Research Focus:metabolism & bioenergetics· 1 Organism:mouse· 1

Frequent Co-Authors

C. Liu· 1 shared D. Li· 1 shared D. Shao· 1 shared F. Guo· 1 shared H. Li· 1 shared H. Zhang· 1 shared J. Cao· 1 shared J. Liu· 1 shared

Activity by Year

2019-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCell Biology

C. Liu

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Oxidative phosphorylation safeguards pluripotency via UDP-N-acetylglucosamine

J. Cao, M. Li, K. Liu, X. Shi, N. Sui, Y. Yao, X. Wang, S. Tan, Q. Zhao, L. Wang, X. Chai, L. Zhang, C. Liu, X. Li, Z. Chang, , T. Zhao

This paper shows that oxidative phosphorylation (OXPHOS) generates most ATP in mouse ESCs and is essential for pluripotency by coupling with the hexosamine biosynthesis pathway to produce UDP-GlcNAc.

bioRxiv · Jul 6, 2021Cell Biology

Frequency of mutations in 21 hereditary breast and ovarian cancer susceptibility genes among high-risk Chinese individuals

D. Shao, S. Cheng, F. Guo, Y. Yuan, K. Hu, Z. Wang, X. Meng, X. Jin, Y. Xiong, X. Chai, H. Li, Y. Zhang, H. Zhang, J. Liu, M. Ye

The paper assesses the frequency of deleterious mutations in 21 hereditary breast and ovarian cancer genes among 882 high-risk Chinese individuals, finding 19.5% carried such mutations, with higher rates in those with both breast and ovarian cancer histories.

Annals of Oncology · Oct 1, 2019Peer-reviewedCancer Biology